fme Life Sciences to offer enterprise content and data management services in support of Ennov’s Regulatory solution suite.
Ennov and global professional services firm fme Life Sciences are pleased to announce a new partnership that will provide an expanded portfolio of content and data management services to their regulatory clients.
The Ennov Regulatory suite combines the power and flexibility of Ennov Doc, Ennov Dossier and Ennov RIM to support the entire regulatory product lifecycle from the early planning of registration targets through product retirement. The Ennov Regulatory suite is an invaluable tool for regulatory activity planning, product registration management, dossier creation, dossier management and more. Within the last twelve months, three of the top 25 pharmaceutical companies have selected Ennov as their global RIM platform to support the regulatory operations of multiple business sectors across their respective organizations.
fme Life Sciences is a leading provider of business and technology services supporting the deployment of Content Services and ECM solutions to its clients in the Life Sciences Industry. They act as a trusted advisor and systems integration specialist across the Clinical, Regulatory and Quality and Manufacturing domains in Europe and North America.
According to Ennov CEO Olivier Pâris,
“The number, size and complexity of our Regulatory projects is always increasing and we must ensure that we can scale our capabilities appropriately to ensure our clients are successful. Our partnership with fme Life Sciences provides our clients with a reliable, high quality provider of enterprise content and data management services as they prepare for their implementation of their Ennov solution.”
“Ennov continue to make a positive impact in the Life Sciences market with their Ennov Regulatory Suite and their acquisition of high profile clients has not gone unnoticed.” commented Nigel Whitehead, COO of fme Life Sciences. “Our mutual clients will clearly benefit from this partnership and we’re looking forward to supporting Ennov’s growth trajectory” he added.